Humacyte Inc (HUMA) Is Not Likely To Be The Same Tomorrow

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Recently, Yahoo Finance discussed the stock, revealing that Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

Humacyte Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $3.87 and fluctuated between $3.9000 as its day high and $3.6150 as its day low. The current market capitalization of Humacyte Inc is $400.85M. A total of 0.92 million shares were traded on the day, compared to an average of 1.99 shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, HUMA has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 5 BUYs and 15 SELLs from insiders. Insiders purchased 297,949 shares during that period but sold 20,997,594.

In the most recent transaction, Dougan Brady W sold 2,000,000 shares of HUMA for 2.78 per share on Sep 14. After the transaction, the Director now owns 6,191,140 company shares. In a previous transaction on Sep 14, Niklason Laura E sold 2,000,000 shares at 2.78 per share. HUMA shares that President, CEO and Director owns now total 6,191,140.

Among the insiders who sold shares, Ayabudge LLC disposed of 602,443 shares on Aug 21 at a per-share price of $3.39. This resulted in the 10% Owner holding 8,191,140 shares of HUMA after the transaction. In another insider transaction, Dougan Brady W sold 602,443 shares at $3.39 per share on Aug 21. Company shares held by the Director now total 8,191,140.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for HUMA in the last 3 months, the mean price target is $7.00 with high estimates of $15.00 and low estimates of $3.00. In terms of 52-week highs and lows, HUMA has a high of $5.60 and a low of $1.96.

As of this writing, HUMA has an earnings estimate of -$0.24 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$0.2 per share and a lower estimate of -$0.27.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. HUMA’s latest balance sheet shows that the firm has $225.50M in Cash & Short Term Investments as of fiscal 2021. There were $51.18M in debt and $11.05M in liabilities at the time. Its Book Value Per Share was $0.36, while its Total Shareholder’s Equity was $122.17M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HUMA is Buy with a score of 4.71.

Most Popular

Related Posts